Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0000950170-25-066968
Filing Date
2025-05-08
Accepted
2025-05-08 16:13:00
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3/A crdf_s-3a_5.8.25.htm S-3/A 876540
2 EX-23.1 crdf-ex23_1.htm EX-23.1 5159
3 GRAPHIC img83777979_0.jpg GRAPHIC 13714
4 GRAPHIC img83777979_1.jpg GRAPHIC 99637
5 GRAPHIC img83777979_2.jpg GRAPHIC 13714
6 GRAPHIC img83777979_3.jpg GRAPHIC 13714
  Complete submission text file 0000950170-25-066968.txt   1077425
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

EIN.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-285327 | Film No.: 25926242
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)